Novartis India Limited has completed the e-mailing of postal ballot notices to its members and published regulatory newspaper advertisements on April 17, 2026, under SEBI Listing Regulations. The pharmaceutical company filed a formal intimation with BSE Limited regarding the completion of the e-mailing process and subsequent newspaper publication.

Updated Regulatory Compliance Notice

The company filed an updated intimation with BSE Limited regarding the publication of newspaper advertisements in Financial Express and Navshakti on April 17, 2026. This notice was submitted pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming the completion of e-mailing postal ballot notices to members.

Postal Ballot Timeline and Process

The postal ballot notice was e-mailed to members on Thursday, April 16, 2026. The cut-off date for determining eligible members was set as Friday, April 10, 2026. Remote e-voting commenced on Friday, April 17, 2026, at 9:00 AM (IST) and will conclude on Saturday, May 16, 2026, at 5:00 PM (IST).

Corporate Communication Details

Company Secretary and Compliance Officer Chandni Maru signed the regulatory communication on behalf of Novartis India Limited. The notice was digitally signed on April 17, 2026, at 10:57:39 +05'30' and submitted to BSE Limited's corporate communications department.

Regulatory Framework Compliance

The postal ballot process is being conducted in accordance with Sections 110 and 108 of the Companies Act, 2013, Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014, and SEBI Listing Regulations. The company is also following Secretarial Standards on General Meetings issued by The Institute of Company Secretaries of India and various MCA circulars for conducting postal ballot processes through e-voting.

Scrutinizer Appointments

The Board of Directors has appointed Mr. S.N. Vishwanathan (ACS 19858; COP No. 24335) as the Scrutinizer and Mrs. Ashwini Vartak (ACS 21463; COP No. 16023) as the Alternate Scrutinizer to oversee the e-voting process in a fair and transparent manner.

Novartis India Limited has announced a postal ballot process to seek shareholder approval for the appointment of Ms. Gowree Gokhale as Non-Executive and Independent Director. The pharmaceutical company issued the notice on April 16, 2026, outlining the e-voting procedure and timeline for this corporate governance matter.

E-Voting Schedule and Process

The remote e-voting process has been structured with specific timelines to ensure adequate participation from shareholders. The company has appointed MUFG Intime India Private Limited as the registrar and NSDL as the e-voting service provider.

The notice was sent electronically to all members whose email addresses are registered with the company or depositories as on the cut-off date. Advertisements regarding the postal ballot were published in Financial Express (English) and Navshakti (Marathi) on Monday, April 13, 2026.

Director Appointment Details

Ms. Gowree Gokhale (DIN: 09351661) is proposed to be appointed for a term of five consecutive years from April 01, 2026, to March 31, 2031. This appointment comes as Ms. Sandra Martyres' second term as Independent Director concludes on April 18, 2026.

Professional Background

Ms. Gokhale brings extensive legal expertise to the board with over 30 years of diverse experience. She is a distinguished Solicitor of the Bombay Incorporated Law Society and holds an L.L.M from Mumbai University with specialization in Intellectual Property, Labour, Tax, and Consumer Protection laws.

Her professional experience includes:

• 22 years with Nishith Desai Associates, co-leading Pharma and Medical Devices practice areas
• Current independent chamber practice
• Expertise in Intellectual Property, Data Protection, Consumer Protection, Mergers & Acquisitions, Joint Ventures, and Competition Law
• Advisory roles across multiple industries including Pharma, Healthcare, Telecom, E-Commerce, AI, Fintech, Gaming, Media, and Entertainment

Regulatory Compliance

The appointment aligns with SEBI Listing Regulations requirements. Under Regulation 17(1)(c), the board must comprise at least six directors, while Regulation 17(1C) read with Regulation 25(2A) mandates shareholder approval for Independent Director appointments within three months of appointment.

The company has received Ms. Gokhale's declaration of independence, confirming she meets the criteria under Section 149(6) of the Companies Act, 2013, and Regulation 16(1)(b) of SEBI Listing Regulations. She has successfully registered in the Independent Director's Data Bank maintained by the Indian Institute of Corporate Affairs.

Scrutinizer Appointment

The board has appointed qualified professionals to oversee the e-voting process:

Shareholders can access the complete notice and voting instructions on the company's website at www.novartis.in , BSE's website, and NSDL's e-voting portal. The resolution, if passed with requisite majority, will be deemed effective from the last date of e-voting, May 16, 2026.